Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Study: Comparison of amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders

18 Oct, 2020 | 23:00h | UTC

Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial – The Lancet Psychiatry (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.